Connect
MJA
MJA

Depression and physical illness: more complex than simple comorbidity

David M Clarke
Med J Aust 2009; 190 (7): S52-S53. || doi: 10.5694/j.1326-5377.2009.tb02470.x
Published online: 6 April 2009

Abstract

Depression alone is debilitating, and this effect is multiplied in people with physical illness

Depression is common when people have physical illness — every clinician knows that. And, as may be expected, the literature confirms that depression is worse with more severe disease, especially when there is poor social support and other adverse life situations.1 What has been freshly highlighted over recent years, however, is the enormous impact of depression. Depression alone produces a level of disability equivalent to any other chronic disease and, when combined with physical illness, this effect is multiplied.2 The recent World Health Organization World Health Surveys indicated that depression produced the greatest decrement in health of any chronic disease, and the comorbid state of depression incrementally worsened health more than any other disease combination.3 Depression also increases consumption of health care resources; depression was associated with a 17%–46% increase in health costs in the large WHO LIDO study.4

So why don’t we do something about this? There are a number of issues here. First, we would all accept that much sadness and upset in life are understandable. However, that doesn’t remove the imperative to help and to relieve the suffering. Indeed, understanding the depression (as psychiatrists spend time trying to do) is the first step toward knowing how to respond. Having a debilitating or life-limiting disease will make some people depressed — in a similar way, perhaps, to grief. Having unrelenting pain wears down the spirit. Having advancing disease makes a person feel helpless. Facing an uncertain future creates apprehension. All these experiences can be part of what we call depression in the physically ill, and this depression may also include feelings of shame, guilt and loss.5 Teasing out these phenomenological differences will help us respond appropriately.

Second, we need to know what to do, and it is important to recognise that simple things can often help. For example, giving good information to patients in a supportive and caring manner reduces anxiety and increases the sense of competence (reducing helplessness) and, although not sufficient on its own, is a central component of chronic disease management.6 Participating in professionally led patient support groups also significantly reduces depression and improves coping.7

There are effective treatments (although more research into these is needed) (Clarke & Currie),8 and we know in part what works. The third issue, therefore, is how to implement what we already know, and this is where things are not so simple.

The WHO studies described above highlight the interaction between depression and physical illness. Each contributes to the worsening of the other. People are not going to get better unless both (or all) dimensions are tackled, and so we need new models that acknowledge this complexity.9 These new models for clinical practice will need to be integrated. It is the same person who is depressed, has the physical illness and is socially isolated, so it is not possible to deal effectively with any one of these aspects alone. However, health care administration — at both government and health service levels — separates physical care from mental health care. This is not effective, efficient or cheap.10 While this Supplement highlights the mental health problems associated with physical disease, there has been recent concern about the poor physical health of patients within mental health services.11 It is now time to put into place structures that integrate physical and psychosocial health care. Such integration is absent from the National Chronic Disease Strategy; the word “depression” does not even appear in the National Service Improvement Frameworks.12 Integration of physical and psychosocial health care will not happen without proper resources and, at present, the resources given to the mental health aspect are proportionately much less than the burden of disease attributable to it,13 despite recent significant increases to the funding of mental health services in Australia. Physical health and mental health are closely linked,14 so we return to the issue of complexity and the need for models of integrated care. Such models do exist,15 but will take commitment and money16 to introduce and evaluate.

One field in which there is substantial evidence for the benefit of psychosocial interventions is that of cancer. This evidence is summarised in the National Health and Medical Research Council (NHMRC) Clinical practice guidelines for the psychosocial care of adults with cancer.17 Unfortunately, these guidelines have not been widely implemented in clinical practice. Kelly and Turner, in this Supplement, provide some suggestions to move this forward.18

In the area of heart disease, there have been a number of clinical trials of the effectiveness of antidepressant medication19 or psychotherapy20 to treat depression. These have shown modest effects, and have served to demonstrate how difficult it is to run trials in this field. Over the past few years, “beyondblue: the national depression initiative” has been developing partnerships with physical disease groups such as the Heart Foundation and Cancer Australia to sponsor research that integrates care for people with depression and physical illness. Chronic disease management models are being introduced to prevent the progress and secondary morbidity of chronic disease. It should be a relatively simple matter to incorporate methods for recognising and managing depression into these models.

  • David M Clarke

  • Psychological Medicine, Monash University, Melbourne, VIC.


  • 1. Wilhelm K, Mitchell P, Slade T, et al. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Dis 2003; 75: 155-162.
  • 2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
  • 3. Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851-858.
  • 4. Chisholm D, Diehr P, Knapp M, et al. Depression status, medical comorbidity and resource costs: evidence from an international study of major depression in primary care [LIDO]. Br J Psychiatry 2003; 183: 121-131.
  • 5. Clarke DM, Cook KE, Coleman KJ, Smith GC. A qualitative examination of the experience of “depression” in hospitalised medically ill patients. Psychopathology 2006; 39: 303-312.
  • 6. Dennis SM, Zwar N, Griffiths R, et al. Chronic disease management in primary care: from evidence to policy. Med J Aust 2008; 188 (8 Suppl): S53-S56. <MJA full text>
  • 7. Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007: 16: 277-286.
  • 8. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust 2009; 190 (7 Suppl): S54-S60. <MJA full text>
  • 9. Campbell NC, Murray E, Darbyshire J, et al. Designing and evaluating complex interventions to improve health care. BMJ 2007; 334: 455-459.
  • 10. Kathol RG, Clarke DM. Rethinking the place of the psyche in health: toward the integration of health care systems. Aust N Z J Psychiatry 2005; 39: 816-825.
  • 11. Lambert TJR, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 2003; 178 (9 Suppl): S67-S70. <MJA full text>
  • 12. Australian Government Department of Health and Ageing. Health priorities. National Chronic Disease Strategy. http://www.health.gov.au/internet/main/publishing.nsf/Content/pq-ncds (accessed Feb 2009).
  • 13. World Health Organization. Mental health gap action programme (mhGAP): scaling up care for mental, neurological and substance use disorders. Geneva: WHO, 2008. http://www.who.int/mental_health/mhGAP/en/ (accessed Feb 2009).
  • 14. Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet 2007; 370: 859-877.
  • 15. Smith GC. From consultation-liaison psychiatry to integrated care for multiple and complex needs. Aust N Z J Psychiatry 2009; 43: 1-12.
  • 16. Kathol RG, Melek S, Bair B, Sargent S. Financing mental health and substance abuse disorder care with physical health: a look to the future. Psychiatr Clin North Am 2008; 31: 11-25.
  • 17. National Breast Cancer Centre and National Cancer Control Initiative. Clinical practice guidelines for the psychosocial care of adults with cancer. Sydney: National Breast Cancer Centre, 2003. http://www.nhmrc.gov.au/publications/synopses/cp90syn.htm (accessed Dec 2008).
  • 18. Kelly BJ, Turner J. Depression in advanced physical illness: diagnostic and treatment issues. Med J Aust 2009; 190 (7 Suppl): S90-S93. <MJA full text>
  • 19. Glassman AH, O’Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709.
  • 20. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low-perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients [ENRICHD] randomized trial. JAMA 2003; 289: 3106-3116.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.